Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells
Amin Li(Anhui University of Science and Technology), Xiaolong Tang(Anhui University of Science and Technology)
Cited by 1
Related Papers
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy
|BioMed Research International|2021|25
Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
|Journal of Cancer Research and Clinical Oncology|2020|19